Trial Profile

A phase IIb trial CU01 for the treatment of diabetic nephropathy

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 13 Jan 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Dimethyl fumarate (Primary)
Indications Diabetic neuropathies
Focus Therapeutic Use

Most Recent Events

07 Jul 2023 According to a CURACLE media release, company plan to find the optimal dose and patient group and enter phase 3 based on this
10 Aug 2022 New trial record
08 Jul 2022 According to a CURACLE media release, company had received approval from the Ministry of Food and Drug Safety for this study.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com